The Rising Influence of Rising Affluence

[DewDiligence]

ZBH—What outlook do you think the action…is pricing in at $70, which is where there should be some support? Slow recovery plus permanent revenue lost?

At that price, what’s baked in, IMO, is that sales and EPS won’t return to 2019 levels until 2H21 or 1H22. However, the loss of business won’t be permanent. People around the world continue to get older and fatter, which ensures a continuing demand for knee and hip replacements.